Ignite Creation Date:
2024-05-05 @ 10:44 PM
Last Modification Date:
2024-10-26 @ 10:23 AM
Study NCT ID:
NCT01174407
Status:
UNKNOWN
Last Update Posted:
2010-08-03
First Post:
2008-11-19
Brief Title:
Implication of CD35 CD21 and CD55 in Exudative Age-related Macular Degeneration
Sponsor:
Rudolf Foundation Clinic
Organization:
Rudolf Foundation Clinic
Study Overview
Official Title:
Is CD35 CD21 and CD55 Associated With Exudative Age-related Macular Degeneration
Status:
UNKNOWN
Status Verified Date:
2010-08
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine a possible implication of CD21 CD35 and CD55 in the pathogenesis of age-related macular degeneration The aim is to asses a difference in expression rates of these factors on AMD-patients and a healthy control group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None